Login / Signup
CD24 blockade promotes anti-tumor immunity in oral squamous cell carcinoma.
Ke-Long Zou
Zhou Lan
Hao Cui
Yu-Yue Zhao
Wei-Ming Wang
Guang-Tao Yu
Published in:
Oral diseases (2022)
Targeting CD24 could enhance anti-tumor immune response by inhibiting TAMs.
Keyphrases
</>
immune response
signaling pathway
cancer therapy
dendritic cells
inflammatory response